Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021
2.4.1.5. 1-[2-(2‑hydroxy-3‑methoxy-5-(4-carboxyphenylazo) benzaldeneamino)ethyl]−3-methyl-3H-imidazole-3-ium hexafluorophosphate
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
25-hydroxycholesterol 
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
27-hydroxycholesterol
Potential treatment - theoretical effect Natural product Antiviral Aug/10/2020
2’-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
2′-C-methylguanosine
Potential treatment - theoretical effect Experimental Antiviral Oct/29/2020
3,3'-(Biphenyl-4,4'-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonic acid)
Potential treatment - theoretical effect Experimental Antiviral Mar/26/2021
3,3-Dimethyl-N-[4-(piperidin-1-ylcarbonyl)phenyl]butanamide
Potential treatment - theoretical effect Experimental Antiviral Dec/01/2020
3-amino-N-(naphthalene-1-yl)-5-trifluoromethyl)benzamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021
3-vinyl-1,2-dithiacyclohex-4-ene
Potential treatment - theoretical effect Natural product Antiviral Mar/31/2020
3-{[(1R)-1-Benzyl-2-sulfanylethyl]amino}-3-oxopropanoic acid
Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020
3CLpro inhibitor 6e
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/03/2020
3CLpro inhibitor 6j
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/03/2020
3′-(3-methylbut-2-enyl)-3′,4′,7-trihydroxyflavane
Potential treatment - theoretical effect Natural product Antiviral Aug/07/2020
3′-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
4'-Acetamido-4-dimethylaminochalcone
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
4'-Acetamidochalcone
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
4-(2-aminomethyl)benzenesulfonyl fluoride
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/07/2020
4-(3,4-Dihydroxyphenyl)-7-methoxy-5-[(2S,3R,4S,5S)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one
Potential treatment - theoretical effect Natural product Antiviral Sep/08/2020
4-(3-Phenylacryloyloxymethyl)-6,7-dimethoxycoumarin
Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021